Analyze CMMB
Indicators
Fundamentals
— · Not enough data
Market cap
$14.14M
Institutional
Short interest
Analyst target
Annual revenue
$0
Annual net income
$-8.99M
▲ +35.5%YoY
Share count
6.38M
A question the system examines through the data — not advice
Chemomab Therapeutics Ltd. (CMMB) is trading around $1.93 (+7.22% on the last session). Its 52-week range runs from $1.35 to $4.12. Technically: 7 buy signals, 3 sell and 2 neutral. It belongs to the Healthcare sector (Biotechnology) and a 14M$ market cap. Data sourced from Live price as of 23:00. This is data analysis only, not advice or a recommendation.
Disclosure & disclaimer: All information, scores, signals and trade plans on this site are produced by an automated algorithmic system and are based on technical and quantitative data only. They do not constitute investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional that accounts for your needs and circumstances. We are not investment advisors. Trading securities involves substantial risk, up to the loss of your entire investment; every decision and action is your sole responsibility. analysto and its operators bear no liability for any direct or indirect damage arising from reliance on this information.
Neutral — mixed picture
From 13 weighted indicators
Timeframes mixed · Indicator families disagree — less decisive · High volatility · Thin liquidity
13 indicators under fixed, disclosed rules on closed daily bars, each carrying its own weight in the score. Not investment advice or a recommendation.